IX-3000 series (Ionix)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIX-3000 series (Ionix)
Drug Alias NameNav 1.8 antagonist (Ionix)IX-4000 series (Ionix)IX-3300IP-03IX-3200 +[7] 
ClassificationSmall molecules
Mechanisms of ActionSodium channels modulators
TargetsSodium channels
Therapy Area/IndicationsPainUrethral DiseasesIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsPainUrethral DiseasesIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A